IGM Biosciences Inc (IGMS)
9.18
-0.11
(-1.18%)
USD |
NASDAQ |
May 17, 16:00
9.18
0.00 (0.00%)
After-Hours: 20:00
IGM Biosciences Shareholders Equity (Quarterly): 161.25M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 161.25M |
December 31, 2023 | 203.23M |
September 30, 2023 | 253.86M |
June 30, 2023 | 258.61M |
March 31, 2023 | 239.43M |
December 31, 2022 | 287.26M |
September 30, 2022 | 328.18M |
June 30, 2022 | 375.41M |
March 31, 2022 | 204.52M |
December 31, 2021 | 244.91M |
September 30, 2021 | 285.58M |
Date | Value |
---|---|
June 30, 2021 | 322.46M |
March 31, 2021 | 355.61M |
December 31, 2020 | 381.82M |
September 30, 2020 | 188.18M |
June 30, 2020 | 206.95M |
March 31, 2020 | 224.01M |
December 31, 2019 | 240.23M |
September 30, 2019 | 254.62M |
June 30, 2019 | 81.73M |
December 31, 2018 | -65.83M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
81.73M
Minimum
Jun 2019
381.82M
Maximum
Dec 2020
254.89M
Average
249.38M
Median
Shareholders Equity (Quarterly) Benchmarks
Akoya Biosciences Inc | 32.72M |
Xilio Therapeutics Inc | 25.76M |
NovaBay Pharmaceuticals Inc | 0.16M |
Palatin Technologies Inc | 1.579M |
iBio Inc | 9.197M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 376.13M |
Total Liabilities (Quarterly) | 214.88M |
Current Ratio | 7.982 |